Jeanmarie Guenot is the Chief Executive Officer and the President of Amphivena Therapeutics. She has over twenty years of experience in the biotechnology industry and the pharmaceutical industry. She has worked with various company types including pharmaceutical research and development, private and public sector, venture capital, business development, corporate management, and commercial management. Ms. Guenot has a wide range of expertise in building and rebuilding companies. Her current company Amphivena Therapeutics develops bifunctional antibody therapy. Before coming on board Amphivena Therapeutics, Guenot was the founder of SKS Ocular. SKS Ocular is an ophthalmic incubator that is focused on dry AMD. Dr. Guenot has also been an advisor to Hoffmann – LA Roche, in Shanghai and Basel. Dr. Guenot was also the Vice President of Corporate and Business Development at a company called PDL BioPharma at https://www.linkedin.com/in/jeanmarie-guenot-4a140617. At PDL BioPharma, she handled mergers and acquisitions and licensing.
Jeanmarie Guenot has done some axing this when it comes to biotechnology. She single-handedly negotiated the Biogen Idec-PDL collaboration. This collaboration led to a $100 million equity investment. Ms. Guenot has also been instrumental in licensing ophthalmic indication for the drug Ophthotech. Dr. Guenot also started a business career. Her career in business started at a company called Atlas Venture. At Atlas Venture, she was the manager of venture capital investments. She has also been involved in building companies specializing in life science on takeda.com. As a scientist, she worked at the company, Hoffmann-La Roche. She was in charge of developing drugs for autoimmune diseases, oncology, and inflammation. Dr. Jeanmarie Guenot is trained in medicinal chemistry. She focuses mainly in semi-empirical methods and quantum mechanics. She graduated from University of California, where she received her Ph.D. She also recieved her MBA from The Wharton School, which is located at the University of Pennsylvania. Amphivena Therapeutics is a company specializing in the development of innovative therapies. Read more on guenotllc.com